Drug nanoparticles are often used to improve the bioavailability of oral drug delivery. However, due to physiological barriers such as mucus layer, P-glycoprotein(P-gp) efflux, and tight junctions in the gastrointestinal tract, the improvement of bioavailability of oral drugs by nanoparticles is limited. Nanoparticles modified with functional materials have become a research hotspot for oral drug delivery strategies due to their functionality, modifiability, and diversity. This study briefly describes the factors that limit the bioavailability of drugs and focuses on the summary of functional nanomaterials that enhance drug bioavailability by improving drug physicochemical properties and overcoming biological barriers to provide references and literature support for the study of drug loading strategies for poorly soluble drugs.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |